Quat Wipes Provide Broad-Spectrum Disinfection
|
By HospiMedica International staff writers Posted on 27 Jun 2018 |
|
Image: New disinfectant wipes provide aesthetics and cleaning power (Photo courtesy of Clorox Healthcare).
New alcohol-free disinfectant wipes eradicate 44 known pathogens, including bacteria, viruses, and fungi, in two minutes or less.
The Clorox Healthcare (Grapevine, TX, USA) VersaSure Cleaner disinfectant wipes are based on a quaternary ammonium (quat) compound with a low odor, low residue formula with a patented technology that enhances quat surface activity. VersaSure kills influenza, measles, mumps, respiratory syncytial virus (RSV), and other viruses in 30 seconds. Bacteria and fungi, including methicillin-resistant Staphylococcus aureus (MRSA), Vancomycin resistant Enterococcus faecalis (VRE), Escherichia coli (E. coli), salmonella, mycobacterium bovis (TB), and Candida albicans are eradicated in two minutes.
The patented alcohol-free quat technology and innovative wipe design combine to provide excellent aesthetics and cleaning power, delivering broad efficacy and fast kill times without co-active complexes. The low residue formula provides superior staff and patient comfort, with no harsh chemical fumes or odors. The durable, low-linting wipes are textured for greater strength, with excellent wetness that provides high surface coverage, assuring that the treated surfaces will remain wet for the full contact time.
“Not all disinfectants are created equal, and many don’t have the optimal balance of attributes to meet users’ needs. For example, a conventional quat or alcohol-based product might offer good compatibility, but have limited kill claims or evaporate from surfaces before meeting the required contact time,” said Brian Thompson, director of Clorox Healthcare R&D. “We believe healthcare facilities shouldn’t have to make those trade-offs, and with VersaSure, they don’t. Our R&D teams refused to make compromises between efficacy, aesthetics, wetness and cleaning power.”
VersaSure wipes are ready-to-use, fast acting and compatible with a broad range of hard, non-porous surfaces found in healthcare settings. A variety of sizes are available, including multipurpose wipes in 85 and 150 count canisters and 30 count flat packs, terminal wipes for everyday cleaning and disinfecting of large spaces, 110 count buckets, and refill pouches.
Related Links:
Clorox Healthcare
The Clorox Healthcare (Grapevine, TX, USA) VersaSure Cleaner disinfectant wipes are based on a quaternary ammonium (quat) compound with a low odor, low residue formula with a patented technology that enhances quat surface activity. VersaSure kills influenza, measles, mumps, respiratory syncytial virus (RSV), and other viruses in 30 seconds. Bacteria and fungi, including methicillin-resistant Staphylococcus aureus (MRSA), Vancomycin resistant Enterococcus faecalis (VRE), Escherichia coli (E. coli), salmonella, mycobacterium bovis (TB), and Candida albicans are eradicated in two minutes.
The patented alcohol-free quat technology and innovative wipe design combine to provide excellent aesthetics and cleaning power, delivering broad efficacy and fast kill times without co-active complexes. The low residue formula provides superior staff and patient comfort, with no harsh chemical fumes or odors. The durable, low-linting wipes are textured for greater strength, with excellent wetness that provides high surface coverage, assuring that the treated surfaces will remain wet for the full contact time.
“Not all disinfectants are created equal, and many don’t have the optimal balance of attributes to meet users’ needs. For example, a conventional quat or alcohol-based product might offer good compatibility, but have limited kill claims or evaporate from surfaces before meeting the required contact time,” said Brian Thompson, director of Clorox Healthcare R&D. “We believe healthcare facilities shouldn’t have to make those trade-offs, and with VersaSure, they don’t. Our R&D teams refused to make compromises between efficacy, aesthetics, wetness and cleaning power.”
VersaSure wipes are ready-to-use, fast acting and compatible with a broad range of hard, non-porous surfaces found in healthcare settings. A variety of sizes are available, including multipurpose wipes in 85 and 150 count canisters and 30 count flat packs, terminal wipes for everyday cleaning and disinfecting of large spaces, 110 count buckets, and refill pouches.
Related Links:
Clorox Healthcare
New
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
New
Vessel Sealing Instrument
ERGOseal
New
Resorbable Bovine Collagen Membrane
GenDerm
Latest Critical Care News
- Automated IV Labeling Solution Improves Infusion Safety and Efficiency
- First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
- 4D Digital Twin Heart Model Improves CRT Outcomes
- AI Turns Glucose Data Into Actionable Insights for Diabetes Care
- Microscale Wireless Implant Tracks Brain Activity Over Time
- Smart Mask Delivers Continuous, Battery-Free Breath Monitoring
- Routine Blood Pressure Readings May Identify Risk of Future Cognitive Decline
- CGM-Based Algorithm Enhances Insulin Dose Adjustment in Type 2 Diabetes
- Fish Scale–Based Implants Offer New Approach to Corneal Repair
- Dual-Function Wound Patch Combines Infection Sensing and Treatment
- Smartwatch Signals and Blood Tests Team Up for Early Warning on Insulin Resistance
- Smart Fabric Technology Aims to Prevent Pressure Injuries in Hospital Care
- Standardized Treatment Algorithm Improves Blood Pressure Control
- Combined Infection Control Strategy Limits Drug-Resistant Outbreak in NICU
- AI Helps Predict Which Heart-Failure Patients Will Worsen Within a Year
- Algorithm Allows Paramedics to Predict Brain Damage Risk After Cardiac Arrest
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read more
Surgical Techniques
view channel
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read more
New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
Volumetric muscle loss is a traumatic loss of skeletal muscle that often leads to permanent functional impairment and limited reconstructive options. Current experimental strategies struggle to deliver... Read more
Patient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Health IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Business
view channel
GE HealthCare Leads Major European Initiative to Advance Cardio-Oncology Care
Cardiovascular complications are increasingly recognized among people undergoing or recovering from cancer treatment, driven by pre‑existing disease and the cardiotoxic effects of chemotherapy, radiotherapy,... Read more
